January 25, 2015 6:27 PM ET


Company Overview of MAP Pharmaceuticals, Inc.

Company Overview

MAP Pharmaceuticals, Inc., a development stage company, focuses on the enhancement of the therapeutic benefits and commercial attractiveness of proven drugs in the field of neurology through its formulation and inhalation technologies. The company’s lead product candidate includes LEVADEX, an orally inhaled version of dihydroergotamine mesylate (DHE) that has completed Phase III clinical trials for the acute treatment of migraine in adults. Its proprietary technologies consist of particle creation and formulation technologies, which can be applied to small or large molecules, including peptides and proteins; and aerosol delivery platforms, such as TEMPO inhaler, a pressurized metered dose in...

2400 Bayshore Parkway

Suite 200

Mountain View, CA 94043

United States

Founded in 2003

121 Employees





Key Executives for MAP Pharmaceuticals, Inc.

Chief Executive Officer and President
Age: 51
Age: 60
Chief Financial Officer
Age: 47
Senior Vice President
Age: 56
Senior Vice President of Neurology Franchise
Age: 43
Compensation as of Fiscal Year 2014.

MAP Pharmaceuticals, Inc. Key Developments

MAP Pharmaceuticals, Inc.(NasdaqGS:MAPP) dropped from NASDAQ Biotechnology Index

MAP Pharmaceuticals, Inc. will be removed from NASDAQ Biotechnology Index.

MAP Pharmaceuticals, Inc.(NasdaqGS:MAPP) dropped from NASDAQ Composite Index

MAP Pharmaceuticals, Inc. will be removed from NASDAQ Composite Index.

MAP Pharmaceuticals, Inc. Announces Board Changes

On March 1, 2013, Thomas A. Armer, Gerri A. Henwood, Bernard J. Kelley, Matthew V. McPherron, Timothy S. Nelson, W. James O’Shea, Scott R. Ward and H. Ward Wolff resigned as directors of MAP Pharmaceuticals, Inc. and David E.I. Pyott, Jeffrey L. Edwards and Arnold A. Pinkston became directors of MAP.

Similar Private Companies By Industry

Company Name Region
MEBO International, Inc. United States
Vascular Genetics Inc. United States
RPI Finance Trust United States
Intervet, Inc. United States
Leukogene Therapeutics, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MAP Pharmaceuticals, Inc., please visit www.mappharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.